Full Text View
Tabular View
No Study Results Posted
Related Studies
Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
This study is currently recruiting participants.
Verified September 2012 by National Institutes of Health Clinical Center (CC)
Study NCT00069329   Information provided by National Institutes of Health Clinical Center (CC)

First Received on September 22, 2003.   Last Updated on May 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nervous System Malformations
Arthropathy, Neurogenic
Urticaria
Papilledema
Additional conditions recognized in this trial
Congenital Abnormalities
Cryopyrin-Associated Periodic Syndromes
Joint Diseases
More general conditions related to this trial
Cranial Nerve Diseases
Eye Diseases
Genetic Diseases, Inborn
Hereditary Autoinflammatory Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Musculoskeletal Diseases
Nervous System Diseases
Optic Nerve Diseases
Skin Diseases
Skin Diseases, Genetic
Skin Diseases, Vascular
Interventions listed in this trial
Anakinra
Additional drug interventions recognized in this trial
Interleukin 1 Receptor Antagonist Protein
More general drug interventions related to this trial
Antirheumatic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services